Study of the effects of AMG(alpha1-micoroglobulin) reduction rates on the survival, complications and prognosis in dialysis patients

Study of the effects of AMG(alpha1-micoroglobulin) reduction rates on the survival, complications and prognosis in dialysis patients - JAMREDS Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038457

Enrollment

4000

Registered

2019-11-01

Start date

2020-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hemodialysis in out-patients

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Stable hemodialysis out-patients. Patients who were more than 6 months post-dialysis initiation.

Exclusion criteria

Exclusion criteria: Patients with malignancy, clinically overt infection, acute or severe illness, dementia and dialysis re-initiation after functional loss of transplanted kidney.

Design outcomes

Primary

Measure	Time frame
Survival and cardiovasculardisease events	—

Secondary

Measure	Time frame
Survival or cardiovascular disease events	—

Countries

Japan

Contacts

Public ContactYoshiaki Takemoto

Osaka City University Urology

ytakemoto@msic.med.osaka-cu.ac.jp06-6645-2393

Outcome results